Theravance Biopharma ( NASDAQ:TBPH ) First Quarter 2024 Results Key Financial Results Revenue: US$14.5m (up 39% from 1Q...
Theravance's (TBPH) first-quarter 2024 earnings beat estimates while revenues meet the same.
Theravance Bio (TBPH) delivered earnings and revenue surprises of 52.63% and 0.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?